advertisement
 |
|
Top Stories
The acquisition of biopharmaceutical company TESARO is expected to strengthen GSK's oncology pipeline and commercial footprint.
/ read more /
The company will focus on innovation, growth, and productivity with the creation of new units.
/ read more /
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
advertisement
Meet leading maintenance, reliability, engineering and operations professionals from pharma, medical devices and life science industries for high-value networking and expert knowledge exchange at Pharma TechOps USA 2019 on March 7-8, 2019 in San Diego. Discuss best practice strategies for maintenance and reliability in the pharma, the value proposition of such policies, current and future challenges as well as practical solutions. For more information visit
 https://www.pharma-techops-usa.com/ |
|
|
Industry News
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has made two significant changes to its new 2019 Code of Practice with the aim of boosting business integrity on a global scale.
/ read more /
The companies will offer an IT platform that enhances the visibility and performance of the overall personalized medicine treatment process.
/ read more /
More Industry News
|
|
|
|
advertisement
Exclusive Interview from AAPS
Developing New Technologies in Controlled Release
 Watch Video |
|
|
Supplier News
Lonza and Takeda have furthered their multiproduct partnership through collaborative efforts on a new cancer treatment—Alunbrig (brigatinib).
/ read more /
Taconic Biosciences, a provider of genetically engineered rodent model solutions, sent mice into space to advance research on new therapies for aging-related disease processes.
/ read more /
More Supplier News
|
|
|
Bio/Pharma News
Dublin, Ireland-based biopharmaceutical company Allergan will establish an R&D presence in Cambridge, MA.
/ read more /
The companies will embark on a multi-year research collaboration to develop in-vivo delivery modalities for CRISPR/Cas9 by leveraging ProBioGen's existing technology and expertise.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
The agency revised draft guidance to enable more efficient and successful drug development programs for the treatment or prevention of rare diseases.
/ read more /
|
|
|
Following the defeat of the UK's Prime Minister's proposed Brexit withdrawal deal, substantial uncertainty around Brexit remains and risks to public health and the economy are mounting.
/ read more /
More Regulatory News
|
|
|
|
PACKAGING
Active and intelligent packaging technologies benefit brand owners, caregivers, and patients.
/ read more /
|
|
|
|
|
|
DRUG DEVELOPMENT
While pharma is proving its capabilities to develop novel therapies, the industry still needs to work on manufacturing innovation.
/ read more /
|
|
|
Events
March 3–6, 2019
March 11–13, 2019
March 17–21, 2019
more events |
|
|
eBOOKS
 |
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation—as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing. |
|
|
|
|
|
